The Gains Related to Pulmonary Rehabilitation will Continue in the First Month Following Rehabilitation or not?

Objective: Patients with chronic obstructive pulmonary disease (COPD) admitted to the pulmonary rehabilitation (PR) program may lose their post-PR gains over time. In this study, we aimed to investigate whether the gains after PR continued in the first month following PR. Methods: Patients with COPD who completed the PR program were evaluated retrospectively. The incremental shuttle walking test (ISWT) was used to measure the exercise capacity. In PR, patients were trained in strengthening exercises, cycling, walking band, and respiratory exercises in the presence of physiotherapist 2 days a week for a total of 8 weeks. After PR, patients were asked to record their exercise status each day into an exercise log. Results: A total of 35 patients with COPD (mean age 64±8 years) participated in the study. There was a significant increase in the exercise capacity at the ISWT before and after PR (0.001) and the first month after the PR (p=0.001). In the St. George’s Respiratory Questionnaire, a significant improvement was observed before and after PR and at the first-month follow-up (p

Pulmoner Rehabilitasyona Bağlı Kazanımlar İlk Ayda da Devam Eder Mi?

Amaç: Pulmoner rehabilitasyon (PR) programına kabul edilen kronik obstrüktik akciğer hastaları (KOAH) PR sonrası kazanımlarını zamanla kaybedebilirler. Bu çalışmada, PR sonrası kazanımların PR sonrası ilk ayda devam edip etmediğini araştırmayı amaçladık. Gereç ve Yöntem: PR programını tamamlayan ve birinci ay takip kontrollerine katılan KOAH hastaları retrospektif olarak değerlendirildi. Egzersiz kapasitesini ölçmek için artan hızda mekik yürüme testi (AHMYT) kullanıldı. Sekiz haftalık PR programında haftada 2 gün fizyoterapist eşliğinde güçlendirme egzersizleri, bisiklet, yürüme bandı ve solunum egzersiz eğitimi verildi. PR sonrası hastaların egzersiz durumlarını bir egzersiz günlüğüne kaydetmeleri istendi. Bulgular: Toplam 35 KOAH hastası (ortalama yaş 644) çalışmaya alındı. PR sonrası (p=0.001) ve PR’dan 1 ay sonraki AHMYT’de egzersiz kapasitesinde anlamlı artış saptandı (p=0.001). PR sonrası ve 1. ay kontrolünde St. George solunum anketinde de anlamlı düzelme izlendi (p

Kaynakça

1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436–42.

2. Global Initiative For Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: updated 2014. Available at: https:// goldcopd.org/global-strategy-diagnosis-management-preventioncopd-2016/. Accessed Feb 2, 2019.

3. Lusuardi M, Ambrosino N, Donner CF. Definition and rationale for pulmonary rehabilitation. In: Donner CF, Ambrosino N, Goldstein R, editors. Pulmonary Rehabilitation. London: Hodder Arnold; 2005. p. 1–5.

4. Celli BR. Pathophysiological basis of pulmonary rehabilitation in chronic obstructive pulmonary disease, In: Donner CF, Ambrosino N, Goldstein RS, editors. Pulmonary Rehabilitation. London: Hodder Education; 2005. p. 18–26.

5. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al; ATS/ERS Task Force on Pulmonary Rehabilitation. An Official American Thoracic Society/European Respiratory Society Statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188:e13–64.

6. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173:1390–413.

7. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of Chronic Obstructive Pulmonary Disease. Available at: http://www.goldcopd. org/uploads/users/files/GOLD_Report_2014_Jun11.pdf. Accessed May 5, 2018.

8. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease Eur Respir J 2014;44:1428–46.

9. Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE, Hill CJ, et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J 2014;44:1447–78.

10. Wilson RC, Jones PW. A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exercise. Clin Sci (Lond) 1989;76:277–82.

11. American Thoracic Society. Standardization of Spirometry. Am J Respir Crit Care Med 1995;152:1107–36.

12. Ulubay G, Köktürk N, Görek Dilektaşlı A, Şen E, Çiftci F, Demir T, et al. Turkish Thoracic Society national spirometry and laboratory standards. Tuberk Toraks 2017;65:117–30.

13. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581–6.

14. Yorgancıoğlu A, Polatlı M, Aydemir Ö, Yılmaz Demirci N, Kırkıl G, Naycı Atış S, et al. Reliability and validity of Turkish version of COPD assessment test. Tuberk Toraks 2012;60:314–20.

15. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: The St. George’s Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321–7.

16. Polatlı M, Yorgancıoğlu A, Aydemir Ö, Yılmaz Demirci N, Kırkıl G, Atış Naycı S, et al. Validity and reliability of Turkish version of St. George’s respiratory questionnaire. Tuberk Toraks 2013;61:81–7.

17. Puhan MA, Frey M, Büchi S, Schünemann HJ. The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes 2008;6:46.

18. Janssen DJ, Spruit MA, Leue C, Gijsen C, Hameleers H, Schols JM, et al; Ciro network. Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chron Respir Dis 2010;7:147–57.

19. Jaitovich A, Barreiro E. Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease (COPD): What We Know and Can Do for Our Patients. Am J Respir Crit Care Med 2018;198:175–86.

20. MacIntyre NR. Muscle dysfunction associated with chronic obstructive pulmonary disease. Respir Care 2006;51:840–7.

21. Gea J, Agustí A, Roca J. Pathophysiology of muscle dysfunction in COPD. J Appl Physiol (1985) 2013;114:1222–34.

22. Rabinovich RA, Vilaró J. Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 2010;16:123–33.

23. Gloeckl R, Schneeberger T, Jarosch I, Kenn K. Pulmonary Rehabilitation and Exercise Training in Chronic Obstructive Pulmonary Disease. Dtsch Arztebl Int 2018;115:117–23.

24. Foglio K, Bianchi L, Ambrosino N. Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2-year controlled study. Chest 2001;119:1696–704.

25. Brooks D, Krip B, Mangovski-Alzamora S, Goldstein RS. The effect of postrehabilitation programmes among individuals with chronic obstructivepulmonary disease. Eur Respir J 2002;20:20–9.

26. Spencer LM, Alison JA, McKeough ZJ. Maintaining benefits following pulmonary rehabilitation: a randomised controlled trial. Eur Respir J 2010;35:571–7.

27. Lan CC, Chu WH, Yang MC, Lee CH, Wu YK, Wu CP. Benefits of pulmonary rehabilitation in patients with COPD and normal exercise capacity. Respir Care 2013;58:1482–8.

28. Jácome C, Marques A. Impact of Pulmonary Rehabilitation in Subjects With Mild COPD. Respir Care 2014;59:1577–82.

29. Li Y, Feng J, Li Y, Jia W, Qian H. A new pulmonary rehabilitation maintenance strategy through home-visiting and phone contact in COPD. Patient Prefer Adherence 2018;12:97–104.

Kaynak Göster

Southern Clinics of Istanbul Eurasia
  • ISSN: 2587-0998
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2017

839180